Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma and Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT02534337
What this trial is testing

Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University
Large-scale testing (Phase 3)Study completedNCT00109954
What this trial is testing

Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver Cancer
University of Pittsburgh 120
Not applicableEnrolling By InvitationNCT07088081
What this trial is testing

Evaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain Shams University Hospitals

Who this might be right for
HCC - Hepatocellular CarcinomaImmunotherapyImmune Checkpoint Therapy+3 more
Ain Shams University 30
Post-approval studies (Phase 4)Study completedNCT01332669
What this trial is testing

Drug-eluting Bead in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 200
Testing effectiveness (Phase 2)Looking for participantsNCT06498622
What this trial is testing

Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab

Who this might be right for
Hepatocellular Carcinoma
Anhui Provincial Hospital 45
Not applicableLooking for participantsNCT06999837
What this trial is testing

[68Ga]Ga-PSMA PET/CT in Hepatocellular Carcinoma: Impact of Multiparametric Dynamic Whole-body Imaging and Kinetic Modeling.

Who this might be right for
HCC - Hepatocellular Carcinoma
Nantes University Hospital 40
Not applicableStudy completedNCT01798173
What this trial is testing

Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients

Who this might be right for
Cirrhosis With Hepatocellular CarcinomaCirrhosis Without Hepatocellular Carcinoma
Centre Hospitalier Universitaire Dijon 1,246
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06641453
What this trial is testing

CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Chinese PLA General Hospital 30
Not applicableUnknownNCT05990257
What this trial is testing

CMRA for US-guided-MWA of Liver Tumors

Who this might be right for
Regional AnesthesiaPain ControlMicrowave Ablation+1 more
Lu Wang 122
Not applicableUnknownNCT03338166
What this trial is testing

Role of LDH as a Predictor of Treatment Outcomes in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Assiut University 50
Not applicableUnknownNCT06304766
What this trial is testing

Open Versus Laparoscopic Ablation of Liver Malignancies

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinomaLiver Metastases
Rigshospitalet, Denmark 80
Not applicableUnknownNCT05764551
What this trial is testing

The Application of Serum DNA Methylation for Patients With HCC

Who this might be right for
Hepatocellular Carcinoma
Chiayi Christian Hospital 100
Testing effectiveness (Phase 2)WithdrawnNCT02580253
What this trial is testing

Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University
Post-approval studies (Phase 4)Study completedNCT03963206
What this trial is testing

Cabozantinib toLERANCE Study in HepatoCellular Carcinoma (CLERANCE)

Who this might be right for
Hepatocellular Carcinoma
Hospices Civils de Lyon 110
Not applicableStudy completedNCT02156700
What this trial is testing

Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors

Who this might be right for
HaemangiomaMetastasesCholangiocellular Carcinoma+2 more
University Hospital Dubrava 196
Not applicableStudy completedNCT01355107
What this trial is testing

Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease

Who this might be right for
Hepatitis CLiver CirrhosisCarcinoma, Hepatocellular
University Hospital Freiburg 32
Not applicableStudy completedNCT05239507
What this trial is testing

OREIOS International Study

Who this might be right for
Hepatocellular Carcinoma
AstraZeneca 1,127
Not applicableUnknownNCT04640116
What this trial is testing

TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites

Who this might be right for
Liver DiseasesPortal HypertensionCirrhosis, Liver+2 more
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Ended earlyNCT03829501
What this trial is testing

A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies

Who this might be right for
Squamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Kymab Limited 222
Early research (Phase 1)Ended earlyNCT05757492
What this trial is testing

Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorNon-Small Cell Lung CancerHepatocellular Carcinoma
Coherus Oncology, Inc. 22
Next Page